Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Zynex, Inc. (OTC: ZYXI).

Full DD Report for ZYXI

You must become a subscriber to view this report.


Recent News from (OTC: ZYXI)

Zynex's (ZYXI) CEO Thomas Sandgaard on Q1 2018 Results - Earnings Call Transcript
Zynex, Inc. (ZYXI) Q1 2018 Earnings Conference Call May 08, 2018 11:00 AM ET Executives Thomas Sandgaard - CEO Dan Moorhead - CFO Analysts Howard Halpern - Taglich Brothers Ajay Tandon - SeeThruEquity Mark Rosenberger - the B. Riley FBR Alex Hamilton - CGR Don McDonal...
Source: SeekingAlpha
Date: May, 11 2018 19:58
Zynex, Inc. 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Zynex, Inc. in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 10 2018 14:25
Zynex beats by $0.01, beats on revenue
Zynex ( OTCQB:ZYXI ): Q1 EPS of $0.06 beats by $0.01 . Revenue of $6.9M (+100.6% Y/Y) beats by $0.45M . Press Release More news on: Zynex, Inc., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: May, 08 2018 09:36
Zynex Announces 2018 First Quarter Earnings
ENGLEWOOD, Colo. , May 8, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, tod...
Source: PR Newswire
Date: May, 08 2018 09:19
Zynex Schedules 2018 First Quarter Earnings Release and Webcast
LONE TREE, Colo. , May 1, 2018 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, anno...
Source: PR Newswire
Date: May, 01 2018 09:14
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference
NEW YORK , March 8, 2018 /PRNewswire/ -- OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market presenting companies at the 30 th Annual ROTH Confe...
Source: PR Newswire
Date: March, 08 2018 10:00
Consilium Global Research Issues Quarterly Update on Zynex, Inc (OTCQB: ZYXI)
ST. PETERSBURG, FL / ACCESSWIRE / March 8, 2018 / Consilium Global Research (CGR) an Investor Recognition Company that connects Companies with Investors, today announced that it has issued an Update Report on Zynex Inc. (OTCQB: ZYXI). The Research Update Report is available on Stock Market...
Source: ACCESSWIRE IA
Date: March, 08 2018 09:00
Zynex Appoints New Independent Board Member
ENGLEWOOD, Colo. , March 6, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, t...
Source: PR Newswire
Date: March, 06 2018 13:14
Emerging Developments: New Research on OptimizeRx and Zynex - A Look Ahead into 2018
NEW YORK, NY / ACCESSWIRE / March 5 , 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of OptimizeRx Corp. (OTCQB: OPRX) and Zynex Inc. (OTCQB: ZYXI), including recent technical analysis and consolidated fundamental information. Growth Marke...
Source: ACCESSWIRE IA
Date: March, 05 2018 08:30
Zynex Announces 2017 Fourth Quarter Earnings
ENGLEWOOD, Colo. , Feb. 28, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, t...
Source: PR Newswire
Date: February, 28 2018 09:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-172.893.153.182.8986,495
2018-08-162.8252.892.892.752,880
2018-08-142.802.902.902.8064,308
2018-08-132.902.892.902.57579,403
2018-08-102.712.902.982.4563,432

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1751,34388,03058.3244Short
2018-08-161,0002,88034.7222Cover
2018-08-1517,91926,37767.9342Short
2018-08-1450,58864,30878.6652Short
2018-08-1370,35779,40388.6075Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ZYXI.


About Zynex, Inc. (OTC: ZYXI)

Logo for Zynex, Inc. (OTC: ZYXI)

lt p gt Founded in , Zynex is a leading provider of electrotherapy medical devices for pain management and rehabilitation. Zynex is committed to providing the highest quality patient life through non invasive rehabilitation products including NexWave, a electrotherapy device, and the NeuroMove used for recovery of stroke and spinal cord injury patients. Zynex is also developing a non invasive blood volume monitor for use in hospitals and surgery centers. For additional information, please visit: www.zynex.com. lt /p gt

 

Contact Information

 

 

Current Management

  • Thomas Sandgaard / President, CEO
  • Dan Moorhead / Principal Acct. Officer
  • Joshua Robert Disbrow / Audit Committee Member
    • Joshua R. Disbrow has been employed by us since April , . Prior to the closing of the Merger, Mr. Disbrow was the Chief Executive Officer of Luoxis since January . Mr. Disbrow was also the Chief Operating Officer of Ampio since December . Prior to joining Ampio, he served as the Vice President of Commercial Operations at Arbor Pharmaceuticals, a specialty pharmaceutical company, from May through October . He joined Arbor as that company s second fulltime employee. Mr. Disbrow led the company s commercial efforts from inception to the company s acquisition in and growth to over million in net sales in . By the time Mr. Disbrow departed Arbor in late , he had led the growth of the commercial organization to comprise over people in sales, marketing sales training, managed care, national accounts, and other commercial functions. Mr. Disbrow has spent over years in the pharmaceutical, diagnostic and medical device industries and has held positions of increasing responsibility in sales, marketing, sales management, commercial operations and commercial strategy. Prior to joining Arbor, Mr. Disbrow served as Regional Sales Manager with Cyberonics, Inc., a medical device company focused on neuromodulation therapies from June through April . Prior to joining Cyberonics he was the Director of Marketing at LipoScience, an in vitro diagnostics company. Mr. Disbrow holds an MBA from Wake Forest University.

Current Share Structure

  • Market Cap: $133,076,308 - 03/09/2018
  • Authorized: 100,000,000 - 02/05/2018
  • Issue and Outstanding: 32,457,636 - 02/22/2018
  • Float: 13,500,000 - 12/31/2016

 


Recent Filings from (OTC: ZYXI)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 02 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 06 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: November, 22 2017

 

 


Daily Technical Chart for (OTC: ZYXI)

Daily Technical Chart for (OTC: ZYXI)


Stay tuned for daily updates and more on (OTC: ZYXI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ZYXI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ZYXI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ZYXI and does not buy, sell, or trade any shares of ZYXI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/